RecruitingNCT04644952

The Rise in Robotic Atypical Segmentectomies

The Rise in Robotic Atypical Segmentectomies: A Large Cancer Center Experience


Sponsor

M.D. Anderson Cancer Center

Enrollment

600 participants

Start Date

Sep 15, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is examining the rise of robotic surgery for atypical lung segmentectomies — a precise type of lung surgery that removes a small, targeted segment of a lung lobe rather than the entire lobe. Researchers are collecting data from surgeries performed between 2004 and 2019 to understand outcomes, complications, and how this approach has evolved over time. **You may be eligible if...** - You underwent a lung resection procedure (removal of lung tissue) between 2004 and 2019 **You may NOT be eligible if...** - You did not have a lung resection procedure during the specified time period Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERElectronic Health Record Review

Review of medical records


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04644952


Related Trials